Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders' Equity

Schedule of shareholder's equity

						Accumulated
	Common	Common		Additional		Other				Total
	Stock	Stock Par		Paid-In		Comprehensive		Accumulated		Stockholders’
	Shares	Value		Capital		Income		Deficit		Equity
	(In thousands, except share amounts)
Consolidated balance at December 31, 2024	66,374,549	$	66	$	2,298,849	$	3,314	$	(1,555,224)	$	747,005
Shares issued under stock option and employee stock purchase plans	9,642		—		202		—		—		202
Stock-based compensation	—		—		9,316		—		—		9,316
Unrealized gain on marketable securities	—		—		—		254		—		254
Net loss	—		—		—		—		(53,796)		(53,796)
Consolidated balance at March 31, 2025	66,384,191	$	66	$	2,308,367	$	3,568	$	(1,609,020)	$	702,981

						Accumulated
	Common	Common		Additional		Other				Total
	Stock	Stock Par		Paid-In		Comprehensive		Accumulated		Stockholders’
	Shares	Value		Capital		Income		Deficit		Equity
	(In thousands, except share amounts)
Consolidated balance at December 31, 2023	55,883,377	$	56	$	1,823,168	$	3,308	$	(1,397,361)	$	429,171
Shares issued under stock option and employee stock purchase plans	229,171		—		3,814		—		—		3,814
Shares issued in underwritten offering, net	9,798,000		10		432,288		—		—		432,298
Stock-based compensation	—		—		7,202		—		—		7,202
Unrealized loss on marketable securities	—		—		—		(1,064)		—		(1,064)
Net loss	—		—		—		—		(32,808)		(32,808)
Consolidated balance at March 31, 2024	65,910,548	$	66	$	2,266,472	$	2,244	$	(1,430,169)	$	838,613